La chimiothérapie adjuvante après cystectomie pour tumeur vésicale de stade supérieur ou égal à pT3

Progres en Urologie

Volumn 7, Issue 1, 1997, Pages 102-104

  Schmid, Hans Peter ^a,b   Studer, Urs E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; BLADDER TUMOR; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYSTECTOMY; HUMAN; LYMPHADENECTOMY; PATHOLOGY; PATIENT SELECTION; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; PATIENT SELECTION; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS; URINARY BLADDER NEOPLASMS;

EID: 0031066135     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. FREIHA F., REESE J., TORTI F.M. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J. Urol., 1996, 155, 495-500.
2. LOEHRER P.J. Sr., EINHORN L.H., ELSON P.J., CRAWFORD E.D., KUEBLER P., TANNOCK I., RAGHAVAN D., STUART- HARRIS R., SAROSDY M.F., LOWE B.A., BLUMENSTEIN B., TRUMP D. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma : a cooperative group study. J. Clin. Oncol., 1992, 10, 1066-1073.
3. LOGOTHETIS C.J., DEXEUS F.H., FINN L., SELLA A., AMATO R.J., AYALA A.G., KOLBOURN R.G. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. J. Clin. Oncol., 1990, 8, 1050-1055.
4. SCHMID H.-P., TURNER W.H., MÖHRLE K., STUDER U.E. Influence de la lymphadénectomie et de la localisation des métastases ganglionnaires dans le carcinome vésical invasif sur le pronostic à long terme (abstract). Prog. Urol., in press.
5. SKINNER D.G., DANIELS J.R., RUSSELL C.A., LIESKOVSKY G., BOYD S.D., NICHOLS P., KERN W., SAKAMOTO J., KRAILO M., GROSHEN S. The role of adjuvant chemotherapy following cystectoray for invasive bladder cancer : a prospective comparative trial. J. Urol., 1991, 145, 459-467.
6. SKINNER D.G. Management of invasive bladder cancer : a meticulous pelvic node dissection can make a difference. J. Urol., 1982, 128, 34-36.
7. STERNBERG C N., YAGODA A., SCHER H.I., WATSON R.C., AHMED T., WEISELBERG L.R., GELLER N., HOLLANDER P.S., HERR H.W., SOGANI P.C., MORSE M.J., WHITMORE W.F. Preliminary results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for transitional cell carcinoma of the urothelium. J. Urol., 1985, 133, 403-407.
8. STÖCKLE M., MEYENBURG W., WELLEK S., VOGES G., GERTENBACH U., THÛROFF J.W., HUBER C., HOHENFELLNER R. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2) improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J. Urol., 1992, 148, 302-307.
9. STUDER U.E., BACCHI M., BIEDERMANN C., JAEGER P., KRAFT R., MAZZUCCHELLI L., MARKWALDER R., SENN E., SONNTAG R.W. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer : results of a prospective randomized trial J. Urol., 1994, 152, 81-84.